Your browser doesn't support javascript.
loading
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
Lynch, Patrick M; Burke, Carol A; Phillips, Robin; Morris, Jeffrey S; Slack, Rebecca; Wang, Xuemei; Liu, Jun; Patterson, Sherri; Sinicrope, Frank A; Rodriguez-Bigas, Miguel A; Half, Elizabeth; Bulow, Steffen; Latchford, Andrew; Clark, Sue; Ross, William A; Malone, Bonnie; Hasson, Hennie; Richmond, Ellen; Hawk, Ernest.
Affiliation
  • Lynch PM; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Burke CA; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Phillips R; The Polyposis Registry, St. Mark's Hospital, London, UK.
  • Morris JS; Division of Quantitative Sciences, Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Slack R; Division of Quantitative Sciences, Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Wang X; Division of Quantitative Sciences, Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Liu J; Department of Plastic Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Patterson S; Department of Cancer Prevention and Pop Science, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Sinicrope FA; Division of Gastroenterology, Hepatology and Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rodriguez-Bigas MA; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Half E; Gatroenterology Department, Rambam Medical Center, Haifa, Israel.
  • Bulow S; Hvidore Hospital, Denmark, UK.
  • Latchford A; The Polyposis Registry, St. Mark's Hospital, London, UK.
  • Clark S; The Polyposis Registry, St. Mark's Hospital, London, UK.
  • Ross WA; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Malone B; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Hasson H; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Richmond E; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, The National Cancer Institute, Bethesda, Maryland, USA.
  • Hawk E; Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gut ; 65(2): 286-95, 2016 Feb.
Article in En | MEDLINE | ID: mdl-25792707
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Eflornithine / Adenomatous Polyps / Cyclooxygenase 2 Inhibitors / Celecoxib Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Gut Year: 2016 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Eflornithine / Adenomatous Polyps / Cyclooxygenase 2 Inhibitors / Celecoxib Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Gut Year: 2016 Type: Article Affiliation country: United States